Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors

被引:31
作者
Dekeyne, A [1 ]
Gobert, A [1 ]
Auclair, A [1 ]
Girardon, S [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Ctr Rech Croissy, Dept Psychopharmacol, F-78290 Croissy Sur Seine, France
关键词
DRL; 72-s; antidepressant; serotonin reuptake inhibitor; norepinephrine reuptake inhibitor; dopamine reuptake inhibitor; tricyclics;
D O I
10.1007/s00213-002-1070-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: The differential reinforcement of low-rate 72-s (DRL 72-s) schedule, in which rats must withhold a response for at least 72 s to obtain a reward (generally water), is an attractive procedure for the characterisation of potential antidepressant agents. Indeed, several antidepressants have been shown to improve efficiency (ratio of reinforcement rate to response rate) in this model, either by decreasing response rates and/or by increasing reinforcement rates. Objective: Herein, we compared the actions of antidepressants known to inhibit serotonin (5-HT), norepinephrine (NE) and/or dopamine (DA) reuptake in a food-rewarded DRL 72-s schedule. Methods: Rats trained in a food-rewarded DRL 72-s schedule and showing stable baseline performance were administered with drugs i.p. once a week. In independent experiments, the influence of drugs on food intake, spontaneous locomotor activity and extracellular levels of monoamines in the frontal cortex was evaluated. Results: In confirmation of previous studies, the tricyclic agent imipramine (10.0 mg/kg) and the "atypical" agent mianserin (40.0 mg/kg) significantly increased efficiency. In analogy, the selective NE reuptake inhibitors (NARIs) desipramine (20.0 mg/kg), nortriptyline (2.5 mg/kg) and reboxetine (0.63 mg/kg) all displayed marked enhancements in efficiency. In contrast, the selective 5-HT reuptake inhibitors (SSRIs) citalopram (10.0 mg/kg), fluvoxamine (10.0 mg/kg) and paroxetine (10.0 mg/kg) all significantly decreased efficiency. The mixed 5-HT/NE reuptake inhibitors (SNRIs) venlafaxine (2.5 mg/kg, 10.0 mg/kg) and 533005 (0.16-10.0 mg/kg), likewise, did not increase efficiency. Further, the DA reuptake inhibitors (DARIs) bupropion (0.16-10.0 mg/kg) and GBR12935 (0.63-10.0 mg/kg) had no effect on DRL 72-s performance. All drug classes exerted a similar, mild inhibitory influence on food intake and locomotor behaviour. Imipramine, mianserin and NARIs markedly increased extracellular levels of NE, and SSRIs elevated levels of 5-HT, while SSRIs augmented levels of both. Conclusions: The present experimental procedure demonstrates, in analogy to imipramine and mianserin, robust and consistent increases in efficiency with NARIs. Their effects may be distinguished from a decrease in efficiency elicited by SSRIs, and a lack of activity of SNRIs and DARIs. While the reasons underlying the ineffectiveness of SSRIs (in contrast to previous studies) remain to be clarified, these data underline the importance of adrenergic mechanisms in the control of behaviour under conditions of delayed responding. Further, they support the interest of DRL 72-s procedures for the characterisation of diverse classes of antidepressant agent.
引用
收藏
页码:156 / 167
页数:12
相关论文
共 70 条
[1]   Effect of central 5-hydroxytryptamine depletion on tolerance of delay of reinforcement: evidence from performance in a discrete-trials "time-left" procedure [J].
Al-Ruwaitea, ASA ;
Chiang, TJ ;
Al-Zahrani, SSA ;
Ho, MY ;
Bradshaw, CM ;
Szabadi, E .
PSYCHOPHARMACOLOGY, 1999, 141 (01) :22-29
[2]   Serotonin and tolerance to delay of reward in rats [J].
Bizot, JC ;
Le Bihan, C ;
Puech, AJ ;
Hamon, M ;
Thiébot, MH .
PSYCHOPHARMACOLOGY, 1999, 146 (04) :400-412
[3]  
BIZOT JC, 1988, J PHARMACOL EXP THER, V246, P1144
[4]   Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder [J].
Boix, F ;
Qiao, SW ;
Kolpus, T ;
Sagvolden, T .
BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) :153-162
[5]   BIMT 17: a putative antidepressant with a fast onset of action? [J].
Borsini, F ;
Cesana, R ;
Kelly, J ;
Leonard, BE ;
McNamara, M ;
Richards, J ;
Seiden, L .
PSYCHOPHARMACOLOGY, 1997, 134 (04) :378-386
[6]   Current and potential drugs for treatment of obesity [J].
Bray, GA ;
Greenway, FL .
ENDOCRINE REVIEWS, 1999, 20 (06) :805-875
[7]  
BRIGHT F, 1997, J PSYCHOPHARMACOL, V11, pA39
[8]   EFFECTS OF CORTICOTROPIN RELEASING-FACTOR, DESIPRAMINE AND HALOPERIDOL ON A DRL SCHEDULE OF REINFORCEMENT [J].
BRITTON, KT ;
KOOB, GF .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (04) :967-970
[9]   Current concepts in the pharmacological management of obesity [J].
Carek, PJ ;
Dickerson, LM .
DRUGS, 1999, 57 (06) :883-904
[10]   The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats [J].
Cousins, MS ;
Seiden, LS .
PSYCHOPHARMACOLOGY, 2000, 148 (04) :438-442